China SXT Pharmaceuticals, Inc. (SXTC)
5.01
+4.17 (496.43%)
Inactive · Last trade price
on Feb 25, 2025
China SXT Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2016 |
| Cash & Equivalents | 12.07 | 17.37 | 15.52 | 13.33 | 7.29 | Upgrade
|
| Cash & Short-Term Investments | 12.07 | 17.37 | 15.52 | 13.33 | 7.29 | Upgrade
|
| Cash Growth | -30.50% | 11.88% | 16.44% | 82.97% | -20.19% | Upgrade
|
| Accounts Receivable | 1.31 | 1.34 | 3.37 | 4.51 | 3.84 | Upgrade
|
| Other Receivables | 0.03 | 0.23 | 0.66 | 0.65 | 4.37 | Upgrade
|
| Receivables | 1.35 | 1.58 | 5.53 | 6.66 | 9.7 | Upgrade
|
| Inventory | 0.81 | 0.58 | 1.07 | 1.38 | 1.05 | Upgrade
|
| Restricted Cash | 0.01 | - | 0.05 | 0.03 | - | Upgrade
|
| Other Current Assets | - | - | 0.29 | 1.83 | 1.6 | Upgrade
|
| Total Current Assets | 14.23 | 19.52 | 22.45 | 23.23 | 19.64 | Upgrade
|
| Property, Plant & Equipment | 0.56 | 1.27 | 1.59 | 1.79 | 1.9 | Upgrade
|
| Other Intangible Assets | 0.02 | 0.03 | 0.04 | 0.05 | 0.05 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | 0.32 | 0.11 | Upgrade
|
| Other Long-Term Assets | 8.31 | 8.74 | 9.46 | 9.16 | - | Upgrade
|
| Total Assets | 23.13 | 29.55 | 33.55 | 34.55 | 21.7 | Upgrade
|
| Accounts Payable | 1.28 | 1.38 | 1.48 | 1.46 | 1.94 | Upgrade
|
| Accrued Expenses | 1.59 | 1.74 | 2.01 | 1.51 | 0.81 | Upgrade
|
| Short-Term Debt | 3.32 | 8.53 | 10.73 | 12.15 | - | Upgrade
|
| Current Portion of Long-Term Debt | 0.02 | 0.01 | 0.01 | 0.04 | 6.69 | Upgrade
|
| Current Portion of Leases | 0.06 | 0.06 | - | - | - | Upgrade
|
| Current Income Taxes Payable | 1.05 | 1.1 | 1.17 | 1.16 | 0.99 | Upgrade
|
| Current Unearned Revenue | 0.19 | 0.17 | - | - | - | Upgrade
|
| Other Current Liabilities | 1.39 | 1.52 | 1.72 | 2.26 | 1.84 | Upgrade
|
| Total Current Liabilities | 8.9 | 14.5 | 17.12 | 18.58 | 12.26 | Upgrade
|
| Long-Term Debt | 0.12 | 0.12 | - | 0.01 | 0.04 | Upgrade
|
| Long-Term Leases | 0.18 | 0.25 | - | - | - | Upgrade
|
| Total Liabilities | 9.2 | 14.86 | 17.12 | 18.59 | 12.3 | Upgrade
|
| Common Stock | 4.35 | 0.91 | 0.16 | 0.06 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 35.32 | 35.59 | 30.99 | 25.32 | 17.16 | Upgrade
|
| Retained Earnings | -24.71 | -21.61 | -15.69 | -9.95 | -7.2 | Upgrade
|
| Comprehensive Income & Other | -1.03 | -0.2 | 0.96 | 0.53 | -0.59 | Upgrade
|
| Shareholders' Equity | 13.93 | 14.69 | 16.42 | 15.96 | 9.4 | Upgrade
|
| Total Liabilities & Equity | 23.13 | 29.55 | 33.55 | 34.55 | 21.7 | Upgrade
|
| Total Debt | 3.7 | 8.96 | 10.74 | 12.19 | 6.72 | Upgrade
|
| Net Cash (Debt) | 8.38 | 8.41 | 4.78 | 1.14 | 0.56 | Upgrade
|
| Net Cash Growth | -0.39% | 75.82% | 319.07% | 102.64% | -91.13% | Upgrade
|
| Net Cash Per Share | 77.24 | 251.95 | - | - | - | Upgrade
|
| Filing Date Shares Outstanding | 0.43 | 0.07 | 0.01 | - | - | Upgrade
|
| Total Common Shares Outstanding | 0.28 | 0.06 | 0.01 | - | - | Upgrade
|
| Working Capital | 5.33 | 5.02 | 5.33 | 4.65 | 7.37 | Upgrade
|
| Book Value Per Share | 50.24 | 256.97 | 1617.08 | - | - | Upgrade
|
| Tangible Book Value | 13.91 | 14.66 | 16.39 | 15.92 | 9.35 | Upgrade
|
| Tangible Book Value Per Share | 50.17 | 256.48 | 1613.27 | - | - | Upgrade
|
| Machinery | 1.19 | 1.24 | 1.27 | 1.19 | 1.04 | Upgrade
|
| Construction In Progress | - | - | 0.36 | 0.36 | 0.33 | Upgrade
|
| Leasehold Improvements | 1.56 | 1.64 | 1.78 | 1.7 | 1.56 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.